BioSeek

Improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. The company’s BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative activity profiles of each potential drug, assisting in the selection and development of new drug candidates. In February 2010, BioSeek was acquired by Asterand plc (LSE:ATD).